About Pharmacelsus
Pharmacelsus is a company based in Saarbrucken (Germany) founded in 2000 was acquired by GBA Group in February 2017. Pharmacelsus offers products and services including In-Vitro-ADME, In-Vivo-DMPK, and Toxicology Services. Pharmacelsus operates in a competitive market with competitors including Gentronix, Jade Bioscience, Tigermed, Shanghai Yaocheng Health Technology and ReveraGen, among others.
- Headquarter Saarbrucken, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmacelsus Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pharmacelsus
Pharmacelsus offers a comprehensive portfolio of products and services, including In-Vitro-ADME, In-Vivo-DMPK, and Toxicology Services.
Services for absorption, distribution, metabolism, and excretion in drug development
In vivo services for drug metabolism and pharmacokinetics analysis
Testing for toxicity in preclinical drug research and development
Funding Insights of Pharmacelsus
Detailed funding history for Pharmacelsus
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Pharmacelsus
Pharmacelsus has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GBA Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
GBA Group is recognized as a leading life sciences service provider.
|
Locked | Locked | Locked |
Investor details for Pharmacelsus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharmacelsus
Investment portfolio details for Pharmacelsus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pharmacelsus
Detailed financials for Pharmacelsus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmacelsus Comparisons
Peer comparison for Pharmacelsus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharmacelsus
Pharmacelsus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Jade Bioscience, Tigermed, Shanghai Yaocheng Health Technology and ReveraGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| Locked | Locked | Locked |
Provides toxicology, chemistry, and consultancy services for agrochemical industries.
|
|
| Locked | Locked | Locked |
Drug development and preclinical services are provided by Tigermed.
|
|
| Locked | Locked | Locked |
Clinical trial services to biopharma sector are provided.
|
|
| Locked | Locked | Locked |
Steroids for Duchenne muscular dystrophy treatment are developed.
|
|
| Locked | Locked | Locked |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
Detailed competitors of Pharmacelsus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmacelsus
Complete news archive for Pharmacelsus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmacelsus
Pharmacelsus was founded in 2000.
Pharmacelsus is headquartered in Saarbrucken, Germany. It is registered at Saarbrucken, Saarland, Germany.
Pharmacelsus was founded in 2000 as a preclinical contract research organization based in Saarbrucken, Germany. Services provided include in vitro ADME, in vivo DMPK, toxicology, and bioanalytical assays using UHPLC-MSMS and LC-MSMS. In vitro and in vivo pharmacology studies are conducted for conditions such as diabetes, fibrosis, cancer, and non-alcoholic fatty liver disease. Expertise in steroid endocrinology is applied through various screening models for safety and efficacy.
Pharmacelsus's top competitors include PHAXIAM, BioQual and Jade Bioscience.
Pharmacelsus offers In-Vitro-ADME, In-Vivo-DMPK, and Toxicology Services.
Pharmacelsus has 1 investor. Key investors include GBA Group.